Brand name drugs drive up Medicare spending
A new study suggests that cash-strapped Medicare missed an opportunity to save more than $1 billion by not addressing the varying costs and use of prescription drugs. Comparing Medicare enrollees and those on the U.S. Department of Veterans Affairs (VA) health plan, researchers found that Medicare beneficiaries were up to three times more likely than VA patients to choose higher-cost brand name drugs over generic brands, according to the Annals of Internal Medicine report. "The main issue, and the only way to fix this, is to change what physicians are doing," said Dr. Walid Gellad, a lead author and internist with the VA Pittsburgh Healthcare System and the University of Pittsburgh.
- 3 More Pioneer ACOs Say They Will Quit
- Governors Push to Expand Role of PAs, Telemedicine
- Telemetry Overuse Cost Health System $4.8 Million in One Year
- Why Open Payments Irks Physicians
- IV Fluids Shortage Continues
- Ebola in the U.S.: Reason to Fear, to Hope, to Prepare
- Difficult Patients: It's Not Them, It's You, Doctor
- Overcoming a Payer Mix 'Nightmare'
- Proton Beam Therapy Center Closure Illuminates Costs
- Employee Engagement: Make It Meaningful